Daniel E. Geraghty

17.9k total citations · 4 hit papers
147 papers, 13.4k citations indexed

About

Daniel E. Geraghty is a scholar working on Immunology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Daniel E. Geraghty has authored 147 papers receiving a total of 13.4k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Immunology, 20 papers in Genetics and 16 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Daniel E. Geraghty's work include T-cell and B-cell Immunology (78 papers), Immune Cell Function and Interaction (75 papers) and Reproductive System and Pregnancy (47 papers). Daniel E. Geraghty is often cited by papers focused on T-cell and B-cell Immunology (78 papers), Immune Cell Function and Interaction (75 papers) and Reproductive System and Pregnancy (47 papers). Daniel E. Geraghty collaborates with scholars based in United States, South Africa and Japan. Daniel E. Geraghty's co-authors include Akiko Ishitani, Ni Lee, Harry T. Orr, Miguel López‐Botet, Thomas A. Spies, Francisco Navarro, Bo Dupont, Peter Parham, Manuel Llano and Steven G. E. Marsh and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Daniel E. Geraghty

144 papers receiving 13.1k citations

Hit Papers

HLA-E is a major ligand for the natural killer inhibitory... 1992 2026 2003 2014 1998 1994 2005 1992 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
    1998 830 citations Ni Lee, Akiko Ishitani et al. profile →
  2. A second lineage of mammalian major histocompatibility complex class I genes.
    1994 645 citations Daniel E. Geraghty et al. profile →
  3. Nomenclature for Factors of the HLA System, 2004
    2005 537 citations Daniel E. Geraghty, John A. Hansen et al. Human Immunology profile →
  4. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens.
    1992 455 citations Akiko Ishitani, Daniel E. Geraghty profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel E. Geraghty United States 57 11.8k 1.6k 1.3k 1.2k 1.1k 147 13.4k
Joël LeMaoult France 40 4.9k 0.4× 1.3k 0.8× 1.2k 0.9× 406 0.4× 190 0.2× 82 5.7k
Robert DeMars United States 54 6.8k 0.6× 840 0.5× 497 0.4× 1.2k 1.1× 309 0.3× 116 10.5k
Véronique M. Braud France 37 7.0k 0.6× 481 0.3× 327 0.3× 1.3k 1.2× 455 0.4× 72 8.4k
Miguel López‐Botet Spain 60 11.1k 0.9× 429 0.3× 357 0.3× 2.3k 2.0× 826 0.7× 190 12.5k
Peter J. van den Elsen Netherlands 57 6.3k 0.5× 504 0.3× 210 0.2× 623 0.5× 445 0.4× 193 9.8k
P M Starkey United Kingdom 31 2.1k 0.2× 584 0.4× 679 0.5× 401 0.3× 385 0.3× 56 4.5k
Tal I. Arnon Israel 25 4.3k 0.4× 421 0.3× 483 0.4× 771 0.7× 216 0.2× 33 5.1k
Elisabeth H. Weiss Germany 44 3.9k 0.3× 314 0.2× 265 0.2× 724 0.6× 462 0.4× 133 5.9k
Béatrice Riteau France 31 2.8k 0.2× 553 0.3× 529 0.4× 795 0.7× 205 0.2× 42 3.6k
Cristina Bottino Italy 74 19.1k 1.6× 281 0.2× 279 0.2× 1.3k 1.1× 2.1k 1.9× 186 20.9k

Countries citing papers authored by Daniel E. Geraghty

Since Specialization
Citations

This map shows the geographic impact of Daniel E. Geraghty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Geraghty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Geraghty more than expected).

Fields of papers citing papers by Daniel E. Geraghty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel E. Geraghty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Geraghty. The network helps show where Daniel E. Geraghty may publish in the future.

Co-authorship network of co-authors of Daniel E. Geraghty

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel E. Geraghty. A scholar is included among the top collaborators of Daniel E. Geraghty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel E. Geraghty. Daniel E. Geraghty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Lue Ping, George K. Papadopoulos, Jay S. Skyler, et al.. (2024). Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers. Diabetologia. 67(11). 2481–2493.
2.
3.
Dunk, Caroline, Jianhong Zhang, Heyam Hayder, et al.. (2022). Human leukocyte antigen HLA-C, HLA-G, HLA-F, and HLA-E placental profiles are altered in early severe preeclampsia and preterm birth with chorioamnionitis. American Journal of Obstetrics and Gynecology. 227(4). 641.e1–641.e13. 20 indexed citations
4.
Zhao, Lue Ping, Terry P. Lybrand, Peter B. Gilbert, et al.. (2021). Tracking SARS-CoV-2 Spike Protein Mutations in the United States (January 2020—March 2021) Using a Statistical Learning Strategy. Viruses. 14(1). 9–9. 9 indexed citations
5.
6.
Inamoto, Yoshihiro, Paul J. Martin, Mary E.D. Flowers, et al.. (2016). Genetic risk factors for sclerotic graft-versus-host disease. Blood. 128(11). 1516–1524. 9 indexed citations
7.
Prentice, Heather A., Daniel E. Geraghty, Georgia D. Tomaras, et al.. (2014). Immune Correlates Identified in the RV144 Vaccine Efficacy Trial Impact HIV-1 Acquisition Only in the Presence of Certain HLA Class II Genes. AIDS Research and Human Retroviruses. 30(S1). A40–A40.
8.
Wang, Ruihan, Quyen Vu, Nezih Cereb, et al.. (2013). Recombinant structures expand and contract inter and intragenic diversification at the KIR locus. BMC Genomics. 14(1). 89–89. 59 indexed citations
9.
Goodridge, Jodie P., Aura Burian, Ni Lee, & Daniel E. Geraghty. (2013). HLA-F and MHC Class I Open Conformers Are Ligands for NK Cell Ig-like Receptors. The Journal of Immunology. 191(7). 3553–3562. 107 indexed citations
10.
Goodridge, Jodie P., Ni Lee, Aura Burian, et al.. (2013). HLA-F and MHC-I Open Conformers Cooperate in a MHC-I Antigen Cross-Presentation Pathway. The Journal of Immunology. 191(4). 1567–1577. 49 indexed citations
11.
Goodridge, Jodie P., Aura Burian, Ni Lee, & Daniel E. Geraghty. (2010). HLA-F Complex without Peptide Binds to MHC Class I Protein in the Open Conformer Form. The Journal of Immunology. 184(11). 6199–6208. 63 indexed citations
12.
Meresse, Bertrand, Shane A. Curran, Cezary Ciszewski, et al.. (2006). Reprogramming of CTLs into natural killer–like cells in celiac disease. The Journal of Experimental Medicine. 203(5). 1343–1355. 219 indexed citations
13.
Kaiser, Brett K., et al.. (2005). Interactions between NKG2x Immunoreceptors and HLA-E Ligands Display Overlapping Affinities and Thermodynamics. The Journal of Immunology. 174(5). 2878–2884. 169 indexed citations
14.
Ishitani, Akiko, Noriko Sageshima, Ni Lee, et al.. (2003). Protein Expression and Peptide Binding Suggest Unique and Interacting Functional Roles for HLA-E, F, and G in Maternal-Placental Immune Recognition. The Journal of Immunology. 171(3). 1376–1384. 274 indexed citations
15.
Lee, Ni & Daniel E. Geraghty. (2003). HLA-F Surface Expression on B Cell and Monocyte Cell Lines Is Partially Independent from Tapasin and Completely Independent from TAP. The Journal of Immunology. 171(10). 5264–5271. 71 indexed citations
16.
Hunt, Joan S., et al.. (2000). HLA-G in reproduction: studies on the maternal–fetal interface. Human Immunology. 61(11). 1113–1117. 62 indexed citations
17.
Jun, Youngsoo, Eun Ok Kim, Mirim Jin, et al.. (2000). Human Cytomegalovirus Gene Products US3 and US6 Down-Regulate Trophoblast Class I MHC Molecules. The Journal of Immunology. 164(2). 805–811. 95 indexed citations
18.
Navarro, Francisco, Manuel Llano, Teresa Bellón, et al.. (1999). The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. European Journal of Immunology. 29(1). 277–283. 304 indexed citations
19.
Lee, Ni, David R. Goodlett, Akiko Ishitani, Hans Marquardt, & Daniel E. Geraghty. (1998). HLA-E Surface Expression Depends on Binding of TAP-Dependent Peptides Derived from Certain HLA Class I Signal Sequences. The Journal of Immunology. 160(10). 4951–4960. 418 indexed citations
20.
Ishitani, Akiko, et al.. (1994). THE EXPRESSION OF HLA-G ANTIGEN IN DIFFERENT HUMAN TISSUES AND PLACENTAS AT DIFFERENT STAGES OF PREGNANCY. 45(5). 616–625. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joël LeMaoult Breakdown of academic impact, for papers by Robert DeMars Breakdown of academic impact, for papers by Véronique M. Braud Breakdown of academic impact, for papers by Miguel López‐Botet Breakdown of academic impact, for papers by Peter J. van den Elsen Breakdown of academic impact, for papers by P M Starkey Breakdown of academic impact, for papers by Tal I. Arnon Breakdown of academic impact, for papers by Elisabeth H. Weiss Breakdown of academic impact, for papers by Béatrice Riteau Breakdown of academic impact, for papers by Cristina Bottino
Rankless by CCL
2026